Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 9/20 | 0.63 |
| ▸ | SLC6A7 | Q99884 | 1/20 | 0.59 |
| ▸ | GBA1 | P04062 | 1/20 | 0.55 |
| ▸ | RBP4 | P02753 | 1/20 | 0.52 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3411182 | 0.86 | ALDH1A1 (0.67) | SCDGBA1 | |
| SCHEMBL14143825 | 0.86 | SCD (0.55) | SCDSLC6A7GBA1 | |
| SCHEMBL27651267 | 0.82 | SCD (0.61) | SCDGBA1RBP4 | |
| SCHEMBL14130914 | 0.82 | SCD (0.51) | SCDGBA1 | |
| SCHEMBL1822110 | 0.81 | SCD (0.63) | SCDGBA1DCTPP1 | |
| SCHEMBL937373 | 0.80 | SCD (0.72) | SCDDCTPP1 | |
| SCHEMBL1094784 | 0.80 | SCD (0.61) | SCDGBA1DCTPP1 | |
| SCHEMBL3826357 | 0.80 | SCD (0.61) | SCDGBA1DCTPP1 | |
| SCHEMBL2007249 | 0.80 | SCD (0.61) | SCDSLC6A7GBA1DCTPP1 | |
| SCHEMBL3677226 | 0.79 | SCD (0.71) | SCDGBA1DCTPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4439606-A | ANTICHOLESTEROL, ANTILIPEMIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1984-03-27 | — | — | US | claimed |
| US-4439606-A | ANTICHOLESTEROL, ANTILIPEMIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1984-03-27 | — | — | US | disclosed |
| EP-0094498-A2 | Antiatherosclerotic 1-piperazine derivatives | AMERICAN CYANAMID COMPANY (US) | 1983-11-23 | — | — | EP | disclosed |